, is the first organ to degenerate during normal ageing, a process termed age-related thymic involution (thymic involution herein) 6 . Thymic involution is a critical factor in the impaired capacity of adult patients to recover adaptive immunity following therapeutic immune depletion 7 . Thus, development of improved thymus-based therapies for enhancing immune system function in patients is of broad interest. TECs are critical effectors in the intrathymic microenvironments required for T-cell development. Two distinct TEC sublineages exist, located in the cortical and medullary compartments of the thymus 8 . These cortical (c) and medullary (m) TECs mediate discrete aspects of T-cell development, and their segregation into distinct compartments is thought vital for accurate and efficient production of a self-restricted, self-tolerant T-cell repertoire. Despite their functional differences, cTEC and mTEC initially arise from a common progenitor TEC, and the forkhead transcription factor FOXN1, expressed exclusively in thymic and cutaneous epithelia, is required at multiple stages for differentiation of both sublineages 2, 3, 9, 10 . Neonatal thymus transplantation can confer adaptive immunity to congenitally athymic patients 11 but its widespread use is limited by donor tissue supply and histocompatibility; these limitations would be overcome if functional TECs could be generated or expanded in vitro. Several investigators have reported derivation of TEC-like cells from pluripotent cells by directed differentiation using growth factors [12] [13] [14] [15] [16] ; however, neither generation from these TEC-like cells of an organized thymus containing all TEC subtypes, nor their capacity to support T-cell development in vitro has been demonstrated. Although in one report TECs expressing the transcription factor autoimmune regulator (AIRE), which are critical for the establishment of self-tolerance 17 , were detected after transplantation of the pluripotent cell-derived TECs, there, no demarcation of cortical and medullary compartments was evident 16 . In sum, the challenge of generating therapeutically useful TECs in vitro that can form a fully functional thymus on transplantation remains unsolved. Here, we have examined two questions: first, whether the alternative approach of direct reprogramming can be used to generate functional TECs in vitro, and second, whether artificial TECs derived by this method can generate a complete thymus on transplantation.
To address the first question, we tested the outcome of enforcing expression of FOXN1, our candidate reprogramming factor, in primary mouse embryonic fibroblasts (MEFs). For this purpose, we developed a transgenic mouse line in which a full-length Foxn1 complementary DNA under the control of the CAG promoter was knocked into the Rosa26 locus, with a LoxPflanked transcriptional STOP cassette inserted between the CAG promoter and the Foxn1 cDNA (Rosa26 CreERt2/+ control MEFs 10 days after 4OHT treatment, and E15.5 wild-type EpCAM + fetal TEC, normalized to the geometric mean of two housekeeping genes. Data shown are mean ± s.d. from n = 3 independent experiments. (e) Bright-field (left) and immunofluorescence images (right) showing morphology and K8 staining, 10 days after 4OHT treatment. Scale bars, 100 µm. (f) EpCAM and GFP expression 10 days after 4OHT treatment, after gating on live cells. Values shown are mean ± s.d. from n = 3 independent experiments. (g-i) mRNA expression levels of the genes shown in purified EpCAM + iFoxn1 and control MEFs normalized to the geometric mean of two housekeeping genes. Data shown are mean ± s.d. from n = 3 independent experiments (NS, not significant; * P < 0.05). In g, expression level is shown relative to E15.5 EpCAM + fetal TEC or skin. In d,g-i, blue bars, Rosa26
CreERt2/CAG−F oxn1−IRES−GF P (iFoxn1); grey bars, Rosa26
CreERt2/+ (control); black bars, fetal TEC, except right hand panel in g, where black bars represent skin. For c-i n ≥ 3 independent experiments. Three technical replicates were run for each n. cDNA was generated from 200 cells using a one-step RT-qPCR method with amplification (d,g,h) or from 50,000 cells without amplification (i). embryos, from which we derived primary MEFs. Tamoxifen-induced Cremediated excision of the STOP cassette in these MEFs generated Rosa26
CreERt2/CAG−Foxn1−IRES−GFP (iFoxn1) MEFs, in which Foxn1 expression was induced at levels comparable to fetal TECs (Fig. 1b-d) ; tamoxifen-independent Cre-mediated excision was not detected (Supplementary Fig. 2) .
By ten days after initiation of Foxn1 expression, the morphology of iFoxn1 MEFs had changed from an elongated, bipolar shape characteristic of fibroblasts, to a broader, polygonal shape, characteristic of epithelial cells (Fig. 1e) . The identity of these cells was probed using the epithelial-specific markers keratin 8 (K8) and epithelial cell adhesion molecule (EpCAM), which are expressed by all TECs during early thymus development 9, 18 . Most, if not all, iFoxn1 MEFs, but no control MEFs, expressed K8 (Fig. 1e) , and approximately 15% expressed EpCAM (Fig. 1f) , suggesting that FOXN1 induction had converted the fibroblasts to an epithelial-like state.
To is broadly expressed in TECs, and Pax9 and Trp63 (ref. 19) , which are differentially expressed among TEC subsets, were also induced in iFoxn1 MEFs (Fig. 1h ). We consistently detected low levels of endogenous Foxn1 (Fig. 1i) , indicating a direct auto-regulatory mechanism and/or indirect activation of endogenous Foxn1 as part of an initiated TEC differentiation programme. Collectively, enforced FOXN1 expression in MEFs induces genes involved in TEC development and function, suggesting a FOXN1-mediated conversion of MEFs into TEC-like cells (designated iTECs hereafter). FOXN1 is also expressed in cutaneous epithelium, yet here clearly induces a transcriptional programme characteristic of TECs rather than cutaneous epithelium. Although the reasons for this are not understood, the gene expression programme in TECs clearly shares some elements with that of cutaneous epithelium (p63, keratins, some claudins). This may relate to the high levels of FOXN1 induced in our system, and to the intracellular context provided by the iTEC-induction protocol.
To test the functional attributes of the iTECs, we determined their capacity to support T-cell development in vitro. A monolayer of iTECs, in which FOXN1 had been induced for seven days, was seeded with fetal Lin − CD25 − C-Kit + early T lineage progenitors 21 (ETPs). Analysis after 12 days of co-culture (Fig. 2a) revealed the presence of CD4 + CD8 + double-positive (CD4 + CD8 + DP), CD4 + single-positive (CD4 + SP) and CD8 + single-positive (CD8 + SP) cells, with the subset distribution on the iTEC monolayers closely resembling that of the adult mouse thymus (Fig. 2b) . As expected, the T cells generated on the iTEC monolayer expressed both CD3ε and T-cell antigen receptor beta (TCRβ; Fig. 2c,d ). In contrast, ETPs seeded onto control MEFs did not enter thymopoiesis (Fig. 2b) ; instead, most haematopoietic cells remaining after co-culture on MEFs expressed the B-cell marker B220 (Fig. 2c) . Consistent with the requirement for MHC Class II on TECs for positive selection and therefore efficient generation of CD4 + SP thymocytes, EpCAM + iTECs showed robust expression of MHC Class II after co-culture with thymocytes ( Fig. 2e) . Surface MHC Class II was not evident in iTECs before co-culture, demonstrating that the cells generated by the initial reprogramming step differentiated on exposure to developing T cells, as observed for TECs within the native thymus in vivo 22 . Interestingly, the capacity of iTECs to support thymocyte development was dependent on their plating density, with a high density (> 500 cells mm −2 ) producing > 3 times more CD4
+ CD8 + T cells within 12 days than a lower density (< 250 cells mm −2 ; Supplementary Fig. 3 ). However, the addition of fibroblast growth factor 7 (FGF7; ref. 23 ) to low-density iTECs substantially improved their ability to support T-cell development ( Supplementary  Fig. 3 ), consistent with the established role of FGF7 as a mitogen for fetal and postnatal TECs (ref. 23 ). Of note, FGF7 does not affect fibroblast proliferation 24 , and FgfR2IIIb, the receptor for FGF7 and FGF10, is required for normal thymus development 23 . The kinetics of T-cell development were similar when ETPs were seeded onto iTECs or the stromal cell line OP9-DL1 ( Supplementary Fig. 4 ), although as expected, development of CD4 + SP thymocytes was typically more efficient in iTEC cultures ( Supplementary Fig. 4 ). Collectively, iTECs can robustly support T-cell development in vitro, with thymocyte differentiation to the CD4 + and CD8 + SP stages closely mirroring in vivo differentiation. Although further work is required to test the capacity of iTECs to support T-cell development from the circulating lympho-myeloid proliferating progenitor, which is considered to be the thymus-seeding haematopoietic progenitor that gives rise to mature T cells 25, 26 , we anticipate that iTECs will have this capacity as it is well established that lympho-myeloid proliferating progenitors differentiate into T cells in co-culture with OP9-DL1 cells 25, 27, 28 . To address our second question, of whether the iTECs, an artificial cell type generated in vitro, could form an organized and functional thymus, we aggregated iTECs (5 days after induction of FOXN1) or control MEFs with immature thymocytes (CD45 + Lin − ) and fetal thymic mesenchyme from embryos at day 12.5 to 13.5 of development (E12.5-13.5) (CD45 − PDGFRαβ + ), and grafted the resulting cell aggregate under the kidney capsule of syngeneic adult mice 29, 30 ( Fig. 3a) . Fetal thymic mesenchyme was included to ensure that growth factors essential for expansion of the thymus, including FGF10 and IGF (refs 23,31,32) , were available within the graft. Macroscopic, wellformed organs were recovered 4 weeks post-grafting from recipients of iTEC, but not control MEF-only, grafts (Fig. 3b) . These iTEC-derived organs exhibited a characteristic thymus morphology, with multiple clearly defined cortical and medullary regions evident in all grafts (Fig. 3c) . Pan-cytokeratin staining revealed a reticular network of epithelial cells throughout the organs (Fig. 3c) , while flow cytometric analysis indicated that haematopoietic and epithelial cells were present in similar proportions in the recovered iTEC grafts to in the native adult thymus (Fig. 3d) . All EpCAM + cells in the iTEC grafts expressed GFP, reporting the transgenic iFoxn1-IRES-GFP messenger RNA, confirming they were derived from the input iTECs (Fig. 3e) .
Thymus architecture and function are intimately linked, and furthermore, the presence of discrete TEC subsets within the cortical and medullary compartments is required for full functionality of the organ 9 , including for inducing central tolerance in the emerging T-cell repertoire 33 . Correctly compartmentalized regions of cTECs and mTECs were evident in the iTEC-derived grafts, and expressed region-appropriate markers (CD205 and keratin 14 respectively 18, 34 ; Fig. 4a ). The functional cTEC marker β5t (ref. 35) , and the UEA-1 hi subpopulation of mTECs (ref. 9), were also evident (Fig. 4a) (Fig. 4b,c) . iTECs recovered from the grafts expressed a range of markers associated with TEC differentiation and function at or close to the levels normally present in TECs (Fig. 4d) . Thus, iTECs were able to differentiate to generate a functional thymus containing all of the major TEC populations and exhibiting the architectural characteristics diagnostic of a fully functional native thymus.
A crucial question was whether the iTEC-derived grafts supported normal T-cell development, and hence population of the peripheral immune system with newly generated naive T cells. Thymocyte subset distribution in the iTEC-derived grafts closely matched that of the native adult thymus (Fig. 4e,f) . Distribution of TCRβ expression within iTEC grafts was near identical to that observed within the native thymus, with TCRβ hi cells restricted to CD4 + SP and CD8 + SP populations (Fig. 4g) . TCRγδ + T cells were present within CD4 − CD8 − double-negative (DN) populations, again at a comparable proportion in the iTEC grafts and native thymus (Fig. 4h) . No macroscopic grafts were recovered from MEF-graft recipients, and no evidence of thymopoiesis could be found in tissue adjacent to the graft site in any MEF-graft recipient mice (Fig. 4e,f) . The T cells generated in the iTEC grafts were exported to populate the peripheral immune system. Peripheral blood analysis revealed the presence of CD4 + and CD8 + T cells, and Foxp3 + regulatory T cells in two of three nu/nu iTEC recipient mice by 8 weeks post grafting, with numbers continuing to rise over time, whereas no donor-derived peripheral T cells were detected in control mice (Fig. 5a-f , Supplementary  Fig. 5 ). These peripheral T cells expressed normal levels of TCRβ and exhibited CD62LCD44 subset phenotypes consistent with the presence of both naive and activated cells (shown for splenocytes in Fig. 5d,e) . Analysis of both CD44 lo Vβ + and total Vβ + cells present in the spleen and lymph node of iTEC-grafted mice indicated a diverse T-cell repertoire (Fig. 5g) , the functionality of which was demonstrated by cytokine secretion in response to CD3/CD28 crosslinking (Fig. 5h,i) .
The data presented herein establish that enforced expression of FOXN1 is sufficient to convert fibroblasts into iTECs, an in vitro generated cell type that exhibits phenotypic and functional properties of in vivo TECs. They further show that iTECs are able to promote full T-cell development in vitro, potentially offering an improved system for in vitro T-cell development over existing models owing to their capacity to express MHC Class II and thus for selection of CD4
+ SP thymocytes, a characteristic not observed in other models of in vitro T-cell differentiation 36, 37 . iTECs thus represent a clear and essential step towards the generation of patientspecific T cells in culture. They further demonstrate that iTECs generate a properly patterned, functional organ on transplantation in vivo, composed of cTECs and mTECs that express markers diagnostic of each cell type, including markers critical for T-cell lineage differentiation and repertoire selection. To our knowledge this is the first demonstration of the generation of a complete, organized and functional, complex organ from reprogrammed cells. Our data thus identify iTECs as a new and readily available source of TECs, that may provide the basis for thymus transplantation therapies aimed at boosting adaptive immune system function in immunocompromised patients.
METHODS
Methods and any associated references are available in the online version of the paper. 
Mice. Rosa26
CAG−STOP−Foxn1−IRES−GFP/+ mice were backcrossed onto the C57BL/6 background for at least 5 generations then maintained by intercrossing. Rosa26
CreERt2 (ref. 38) mice were maintained as homozygotes. Six-week-to 6-month-old male Rosa26
CreERt2/CreERt2 mice were crossed with 6-12-weekold Rosa26 CAG−STOP−Foxn1−IRES−GFP/+ female mice as described to generate Rosa26
CreERt2/CAG−Foxn1−IRES−GFP (iFoxn1) mice. One pregnant iFoxn1 mouse was euthanized to generate each batch of mouse embryonic fibroblasts (MEFs)/iTECs. For timed matings, noon of the day of the vaginal plug was taken as day 0.5.
Generation of the iFoxn1 targeting vector.
A construct containing the targeting cassette ( Fig. 1a and Supplementary Fig. 1a ) was generated by standard molecular biology techniques and verified by sequencing. Conventional subcloning was used for all cloning steps.
Southern blotting. Genomic DNA was processed for Southern blotting as described previously 9 .
Gene targeting and blastocyst injection. Mouse Sv129/Ola embryonic stem cells (line E14tg2a) were electroporated with linearized targeting vector ( Supplementary  Fig. 1a ) and grown under geneticin selection. Correctly targeted clones were identified by Southern analysis ( Supplementary Fig. 1b ), expanded and injected into C57BL/6 blastocysts to generate chimaeric mice. Germ-line transmission was confirmed for two independently targeted cell clones ( Supplementary Fig. 1b) ; the resulting mouse line was designated Rosa26 CAG−STOP−Foxn1−IRES−GFP/+ (called iFoxn1 herein). The neomycin resistance cassette was removed by crossing of founder iFoxn1 mice with Tg(CAG-FLPe) mice 39 . The E14tg2a embryonic stem cell line used to generate the R26-CAG-STOP-Foxn1-IRES-GFP mouse strain is routinely tested for normal karyotype and is tested free of mycoplasma contamination.
MEF isolation. MEFs were prepared from individual E13.5 embryos decapitated
and stripped of all internal organs and trypsinized into a single-cell suspension. Cells were plated in DMEM containing 10% fetal calf serum, 2 mM sodium pyruvate, 4 mM glutamine, 50 µg ml −1 streptomycin and 50 U ml −1 penicillin (DMEM/FCS). Each MEF line was genotyped using the following primers to detect the iFoxn1 allele: iFoxn1F 5 -GGGAGCAGCTGAAGGATGAC-3 and iFoxn1R 5 -CGCTTGAGGAGAGCCATTTG-3 . Rosa26
CreERt2/CAG−Foxn1−IRES−GFP (iFoxn1) and Rosa26
CreERt2/+ (Control) MEFs were used for all experiments. MEFs were freshly isolated for each experiment performed in this study.
Tamoxifen treatment. Cells were treated with 1 µ M 4-hydroxy tamoxifen (4OHT; Sigma) for 48 h to induce CreERt2. Control MEFs were exposed to an identical 4OHT treatment.
In vitro T-cell development assay. Five days following 4OHT treatment, 5 × 10 4 ('low density') or 1-2×10 5 ('high density') iFoxn1 or control MEFs per well were plated into a 24-well plate. Following a further 2 days, each well was seeded with 3 × 10 3 DN1 thymocytes (Lin − CD25 − c-Kit + ) isolated from E14.5 fetal thymi and then co-cultured in DMEM/FCS supplemented with 1 ng ml −1 rmIL-7 and 5 ng ml −1 rhFlt-3L (PeproTech) for 12 d before analysis. In some experiments 50 ng ml −1 rhFGF-7 (PeproTech) was also added to the medium.
In vitro T-cell development on OP9-DL1 cells. OP9-DL1 cells 36 were plated in 24-well plates at 2×10 4 cells per well. Each well was then seeded with 3×10 3 DN1 thymocytes (Lin − CD25 − c-kit + ) isolated from E14.5 fetal thymi and then cocultured in a-MEM/FCS supplemented with rhFlt3-3L (Peprotech) at 5 ng ml −1 and IL-7 at 5 ng ml −1 or 1 ng ml −1 . Cultures were monitored daily and non-adherent developing T cells were transferred to a fresh monolayer of OP9-DL1 cells every 3-5 d, when the current layer became confluent. The OP9-DL1 cell line was obtained from K. Kranc (MRC CRM, University of Edinburgh, UK), who had recently obtained it from J. C. Zuniga-Pfluker (University of Toronto, Canada). The line is tested free of mycoplasma contamination.
In vitro T-cell stimulation assay. Cells isolated from the lymph nodes of iTEC or control graft recipient mice were plated into a 96-well plate, pre-coated with CD3 and CD28 (BD Biosciences) (3 × 10 5 cells per well), and cultured for 24 h before staining for intracellular IL2 (BD Biosciences, clone JES6-5H4).
Grafts. Here, 2 × 10 5 control or iFoxn1 MEFs (5 days following 4OHT treatment) were mixed with 1 × 10 5 PDGFR-αβ + mesenchymal cells and 1 × 10 5 CD45 + Lin − immature thymocytes isolated from E12.5 to E13.5 fetal thymi, and aggregated for 12-16 h as described 30 . Aggregates were then grafted under the kidney capsule of 6-week-old male CBAxC57BL/6 mice or 5-week-old male nude Foxn1 −/− mice (Harlan or Charles River Laboratories). Grafts were removed from CBAxC57BL/6 mice after 4 weeks for immunohistochemical and flow cytometric analyses as described previously 10 . Blood was drawn from the mandibular vein of nude mice after 6 weeks for flow cytometric analyses.
Antibodies. The antibodies used for immunohistochemistry and flow cytometry are listed in Supplementary Table 1 . Recipient nude mice were euthanized at various time points after grafting, as described, and spleen and lymph node organs were collected for analysis.
Flow cytometry. For analysis, semi-adherent thymocytes were collected from co-cultures by gentle pipetting; adherent MEFs or iTECs were collected by trypsinization. Adult thymi and recovered graft thymi were enzymatically digested to single-cell suspensions as described previously 40 and processed for cytometric analysis without further enrichment. A TCR Vβ screening panel kit (BD Biosciences) was used to analyse TCR Vβ expression on cells mechanically collected from spleen and lymph nodes of mice. Data were acquired using a LSR Fortessa (BD Biosciences) and analysed using FlowJo software (Tree Star).
For sorting, fetal thymi were enzymatically digested to single-cell suspensions as described previously 9, 29 . Total (CD45 + Lin − ) or DN1 (CD45 + Lin − CD25 − c-kit + ) thymocytes were purified after gating against Lin − cells (Lin: CD3 , CD4, CD8, CD11b, CD11c, B220, Gr-1, NK1.1, Ter119). Mesenchymal cells (PDGFRαβ + ) were purified after gating against CD45 − Ter119 − cells. Cell sorting was performed using a FACSAriaII (BD Biosciences).
Immunohistochemistry. Adult thymi and recovered graft thymi were processed for immunohistochemistry as described previously 9 . Isotype controls were included in all experiments. Staining was analysed using a Leica AOBS confocal microscope (Leica Microsystems GmbH). The images presented are either single optical sections or projected focus stacks of serial optical sections.
RNA isolation. RNA was prepared using the RNAeasy mini kit (Qiagen) according to the manufacturer's instructions. All samples were DNase treated.
Quantitative PCR with reverse transcription (RT-qPCR). cDNA was prepared using the Superscript III first strand synthesis kit (Invitrogen) with Oligo-dT primers, according to the manufacturer's instructions. Relative expression levels were determined using the Roche Universal Probe Library on the Roche Lightcycler 480 after normalization to the geometric mean of two housekeeping genes (Hmbs and Tbp) for all experiments. Technical triplicates were run for all samples and no RT and no template controls were included in all experiments. The primers used for RT-qPCR are listed in Supplementary Table 2 . For the analysis presented in Fig. 4d , 50 cells were sorted into CellsDirect 2x Reaction Mix (Invitrogen) supplemented with RNase inhibitor (Ambion). cDNA was synthesized and pre-amplified in a single step using CellsDirect Superscript III reverse transcriptase/Platinum Taq mix (Invitrogen) and gene-specific primers. Thermal cycling conditions were as follows: 50 • C for 15 min; 95 • C for 2 min; 18 cycles of 95 • C for 15 s, 60 • C for 4 min.
Statistical analysis. Statistical analysis was performed using the one-way analysis of variance test (two-tailed), as appropriate for normally distributed data (normal distribution was tested using χ 2 goodness of fit). The α level is taken as 0.05. Errors shown are standard deviations (s.d.) throughout. Sample sizes of at least n = 3 were used for statistical analyses except where indicated. No statistical method was used to predetermine sample size, the experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. There were no limitations on repeatability of the experiments and no samples were excluded from the analysis.
